Search

Your search keyword '"Bonavita, Simona"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Bonavita, Simona" Remove constraint Author: "Bonavita, Simona" Publisher sage publications Remove constraint Publisher: sage publications
32 results on '"Bonavita, Simona"'

Search Results

3. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

5. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

6. Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy

7. Digital work engagement among Italian neurologists

8. Sex effects across the lifespan in women with multiple sclerosis

9. Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis

10. Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience

12. e-Health and multiple sclerosis: An update

13. Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study

14. Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization

15. Fatigue in multiple sclerosis: The contribution of occult white matter damage

16. Distributed changes in default-mode resting-state connectivity in multiple sclerosis

18. Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization

19. Distributed changes in default-mode resting-state connectivity in multiple sclerosis

20. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.

21. Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis.

23. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.

24. Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis.

25. Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

26. Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis.

27. Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

28. Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

29. Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization.

30. e-Health and multiple sclerosis: An update.

31. Fatigue in multiple sclerosis: The contribution of occult white matter damage.

32. Distributed changes in default-mode resting-state connectivity in multiple sclerosis.

Catalog

Books, media, physical & digital resources